InvestorsHub Logo
Followers 107
Posts 4236
Boards Moderated 0
Alias Born 03/16/2017

Re: ORCA post# 53438

Thursday, 03/25/2021 1:40:16 AM

Thursday, March 25, 2021 1:40:16 AM

Post# of 73559
More contracts and purchase orders coming:

Jan 13, 2021
1. A large national hospital chain and a major health insurance company have completed successful testing of the Vitastem product. We are now in the final stages of discussions to determine the size of the initial purchase.

2. Successful product testing was completed by a major midwestern university with whom we are also in discussions regarding their initial product purchase.

3. We have initiated discussions with a major global medical nonprofit that has expressed interest in purchasing Vitastem for use by their doctors and medical staff in treating patients.


These are just the beginning:

Jan 21, 2021
1. "The cost of the licensing agreement is $5000 per practice per month. The current agreement is worth $30,000 per month ($360,000 annually). The first payment of $30,000 is due before the end of January 2021."

March 16, 2021
2. "Debt Free"

3. "we will be able to self-fund all of our operations from this point on and should no longer require to take on any debt."